Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch

International Journal of Colorectal Disease

Volumn 27, Issue 11, 2012, Pages 1455-1463

  Tang, Linda Y ^a   Cai, Hui ^b   Navaneethan, Udayakumar ^a   Boone, James H ^c   Rhodes, Sarah J ^c   Moore, Lauren ^a   Rho, Hyunjin ^a   De La Motte, Carol ^a   Queener, Elaine ^a   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c TECHLAB INC   (United States)

Author keywords

ASCA; Crohn's disease; Fecal; Ileal pouch; Restorative proctocolectomy

Indexed keywords

FUNGUS ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE LIKE CONDITION OF THE POUCH; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL COLON POLYPOSIS; FECES ANALYSIS; FEMALE; HUMAN; ILEITIS; ILEUM DISEASE; ILEUM POUCH; IRRITABLE POUCH SYNDROME; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, FUNGAL; COLONIC POUCHES; CROHN DISEASE; DEMOGRAPHY; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; ROC CURVE; SACCHAROMYCES CEREVISIAE;

EID: 84867978876     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1444-4     Document Type: Article

References (34)

1. Fazio VW, Ziv Y, Church JM et al (1995) Ileal pouch-anal anastomosis: Complications and function in 1005 patients. Ann Surg 222:120-127
2. Sandborn WJ (1994) Pouchitis following ileal pouch-anal anastomosis: Definition, pathogenesis, and treatment. Gastroenterology 107:1856-1860
3. Coffey JC, Winter DC, Neary P et al (2002) Quality of life after ileal pouch-anal anastomosis: An evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis Colon Rectum 45:30-38
4. Stocchi L, Pemberton JH (2001) Pouch and pouchitis. Gastroenterol Clin North Am 30:223-241
5. Castillo E, Thomassie LM, Whitlow CB et al (2005) Continent ileostomy: Current experience. Dis Colon Rectum 48:1263-1268
6. Shen B, Remzi FH, Hammel JP et al (2009) Family history of Crohn's disease increases the risk for Crohn's disease of ileal pouch-anal anastomosis. Inflamm Bowel Dis 15:163-170
7. Shen B, Fazio VW, Remzi FH et al (2007) Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the pouch. Dis Colon Rectum 50:1450-1459
8. Quinton JF, Sendid B, Reumaux D et al (1998) Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 42:788-791
9. Ruemmele FM, Targan SR, Levy G et al (1998) Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 115:822-829
10. Sendid B, Colombel F, Jaquinot PM et al (1996) Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 3:219-226
11. Hoffenberg EJ, Fidanza S, Sauaia A (1999) Serological testing for inflammatory bowel disease. J Pediatr 134:447-552
12. Heelan BT, Allan S, Barnes RM (1991) Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae. Immunol Lett 28:181-185
13. Shen B, Remzi FH, Lavery IC et al (2008) A proposed classification of ileal pouch disorders and associated complications after restorative proctocolectomy. Clin Gastroenterol Hepatol 6:145-158
14. Shen B, Achkar JP, Connor JT et al (2003) Modified pouchitis disease activity index: A simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 46:748-753
15. Sandborn WJ, Tremaine WJ, Batts KP et al (1994) Pouchitis after ileal pouch-anal anastamosis: A pouchitis disease activity index. Mayo Clin Proc 69:409-415
16. Shen B (2009) Crohn's disease of the ileal pouch: Reality, diagnosis and management. Inflamm Bowel Dis 15:284-294
17. Wu AC, Tantisira K, Li L et al (2009) Repeatability of response to asthma medications. J Allergy Clin Immunol 123:385-390
18. Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: Useful, magic, or unnecessary toys? Gut 55:426-431
19. Shen B, Achkar J-P, Lashner BA et al (2001) Endoscopic and histologic evaluations together with symptom assessment are required to diagnose pouchitis. Gastroenterology 121:261-267
20. Navaneethan U, Shen B (2009) Laboratory Tests for Patients With Ileal Pouch-Anal Anastomosis: Clinical Utility in Predicting, Diagnosing, and Monitoring Pouch Disorders. Am J Gastroenterol 104:2606-2615
21. Dubinsky MC, Ofman JJ, Urman M et al (2001) Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 96:758-765
22. Halme L, Turunen U, Heliö T et al (2002) Familial and sporadic inflammatory bowel disease: Comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol 37:692-698
23. Peeters M, Joossens S, Vermeire S et al (2001) Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 96:730-734
24. Norman GL (2001) Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease. Clin Applied Immunol Rev 2:45-63
25. Annese V, Piepoli A, Perri F et al (2004) Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: Comparison of different assays and correlation with clinical features. Aliment Pharmacol Thera 20:1143-1152
26. Melmed GY, Fleshner PR, Bardakcioglu O et al (2008) Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 51:100-108
27. Dendrinos KG, Becker JM, Stucchi AF et al (2006) Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. J Gastrointest Surg 10:1060-1064
28. Vasiliauskas EA, Kam LY, Karp LC et al (2000) Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 47:487-496
29. Desir B, Amre DK, Lu SE et al (2004) Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin Gastroenterol Hepatol 2:139-146
30. Parsi MA, Shen B, Achkar JP et al (2004) Fecal lactoferrin for diagnosis of symptomatic patients with ileo pouch-anal anastamosis. Gastroenterology 126:1280-1286
31. Thomas P, Rihani H, Røseth A et al (2000) Assessment of ileal pouch inflammation by single stool calprotectin assay. Dis Colon Rectum 43:214-220
32. Johnson MW, Maestranzi S, Duffy AM et al (2008) Fecal calprotectin: A noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol 20:174-179
33. Melton GB, Fazio VW, Kiran RP et al (2008) Long-term outcomes with ileal pouch-anal anastomosis and Crohn's disease: Pouch retention and implications of delayed diagnosis. Ann Surg 248:608-616
34. Shen B, Patel S, Lian L (2010) Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther 31:745-753